Obsidian Therapeutics Inc.(OBX:US)
Market Cap$724.98M
Key Metrics
Price$11.77
Revenue (TTM)-
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-
EBITDA (TTM)-
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$26.44M
Total Assets$70.14M
Net Assets-$276.2M
Total Debt$3.6M
Key Metrics
Price$11.77
Revenue (TTM)-
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-
EBITDA (TTM)-
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$26.44M
Total Assets$70.14M
Net Assets-$276.2M
Total Debt$3.6M
Financials
| Name | Mar 31, 2026 | Mar 31, 2025 |
|---|---|---|
Revenue | $0 | $0 |
Cost of Revenue | - | - |
Gross Profit | - | - |
| $20.28M | $26.6M | |
| Research and Development | $15.73M | $21.13M |
| Selling, General, and Administrative | $4.55M | $5.48M |
| Other Operating Expenses | - | - |
Operating Income | -$20.28M | -$26.6M |
| $647K | $1.62M | |
| Non-Operating Interest Income | $647K | $1.62M |
| Non-Operating Interest Expense | - | - |
| Other Income/Expense | - | - |
Income Before Tax | -$19.63M | -$24.99M |
Income Tax | $0 | $0 |
Net Income | -$19.63M | -$24.99M |
Minority Interests | - | - |
Preferred Stock Dividends | - | - |
Net Income to Common | -$19.63M | -$24.99M |
Shares Outstanding (Basic) | 61.6M | 61.6M |
Shares Outstanding (Diluted) | 61.6M | 61.6M |
EPS (Basic) | -$0.32 | -$0.41 |
EPS (Diluted) | -$0.32 | -$0.41 |
EBIT | -$20.28M | -$26.6M |
EBITDA | -$19.94M | -$26.23M |